• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, December 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Commentary: Modifications to Medicare rules could support care innovation for dialysis

Bioengineer by Bioengineer
April 19, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Considering QOL for end-stage kidney disease patients

ATLANTA –In a commentary published in the American Journal of Kidney Diseases, public health researchers suggest adjustments to recently proposed rule changes on how Medicare pays for dialysis services.

Medicare spends approximately $35 billion annually on care for beneficiaries with end-stage renal disease (kidney failure), more than 7 percent of Medicare’s total paid claims. Over half a million people receive regular dialysis treatments to manage this condition, with treatment costs averaging about $85,000 a year, according to the study.

“A year ago, rule changes were proposed that would limit how many dialysis treatments per week Medicare would pay for,” says first author Adam S. Wilk, PhD. “Nephrologists, patients and other interest groups expressed concern that this would have the effect of limiting dialysis patients’ access to innovations in treatment, like ‘frequent hemodialysis,’ that have the potential to improve outcomes and quality of life in this population.” Wilk is assistant professor of health policy and management at the Emory Rollins School of Public Health.

Under the current system, Medicare covers three hemodialysis treatments weekly per patient, but it will often pay for additional treatments when the treating nephrologist provides sufficient medical justification. The recently proposed rule changes would limit such additional payments to exceptional circumstances (for example, patients with temporary, acute kidney treatment needs). Although nephrologists would not be prevented from providing any “extra” treatments they believe are needed, they would typically bear the costs of doing so.

In their article, Wilk and colleagues discussed the limitations of the current evidence on frequent dialysis treatment, which to date has yielded mixed conclusions. The researchers’ suggested changes to Medicare’s dialysis payment system were designed to account for these limitations and give Medicare the flexibility to further modify the system in the future as new evidence comes to light. Under the most provocative of their proposals, Medicare would establish a new, separate prospective payment system for frequent hemodialysis treatment.

“If Medicare were to adopt the policy options we describe, nephrologists would have greater clarity about how they would be paid for their dialysis care, giving them greater freedom to identify better ways to treat their dialysis patients. Given the poor prognoses most patients undergoing dialysis have, such innovations are greatly needed to improve this population’s longevity and quality of life,” says Wilk.

###

Media Contact
Holly Korschun
[email protected]

Related Journal Article

http://news.emory.edu/stories/2019/04/wilk_dialysis_medicare/index.html
http://dx.doi.org/10.1053/j.ajkd.2019.01.027

Tags: Health CareHealth Care Systems/ServicesInternal MedicineMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

RETREAT-FRAIL Trial Revolutionizes Hypertension Management in Seniors

December 19, 2025

Macular Vessel Density: A New Glaucoma Biomarker

December 19, 2025

HPV’s Role in Ovarian Cancer: Mechanisms and Treatments

December 19, 2025

Somali American Women: Insights on Cervical Cancer Screening

December 19, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    70 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    53 shares
    Share 21 Tweet 13
  • MoCK2 Kinase Shapes Mitochondrial Dynamics in Rice Fungal Pathogen

    72 shares
    Share 29 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

RETREAT-FRAIL Trial Revolutionizes Hypertension Management in Seniors

AI’s Transformative Impact on Web Development’s Future

Macular Vessel Density: A New Glaucoma Biomarker

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.